Home > Global Health Program > Priority Diseases & Conditions > Malaria > Announcements
Global Development Program
United States Program
For Grant Seekers
Newsroom
Grantee Profiles
About Us
December 4, 2007

Infectious Disease Research Institute Receives Grant for Adjuvant Access and Development


View printable version    

SEATTLE -- The Infectious Disease Research Institute (IDRI), a Seattle-based nonprofit scientific research institute, announced today that it has received a $29,947,850 five-year grant from the Bill & Melinda Gates Foundation. The grant will be used to provide adjuvants (essential components for many vaccines) for priority malaria vaccine candidates. Advances arising from this project are likely also to facilitate development of vaccines against other neglected diseases.

To read the full press release, visit the IDRI Web site.

Go to Web site

###
Bill & Melinda Gates Foundation
Guided by the belief that every life has equal value, the Bill & Melinda Gates Foundation works to help all people lead healthy, productive lives. In developing countries, it focuses on improving people's health and giving them the chance to lift themselves out of hunger and extreme poverty. In the United States, it seeks to ensure that all people—especially those with the fewest resources—have access to the opportunities they need to succeed in school and life. Based in Seattle, the foundation is led by CEO Patty Stonesifer and co-chair William H. Gates Sr., under the direction of Bill and Melinda Gates and Warren Buffett.

Run Search
Advanced Search
Mar 7, 2008
Update on Gates Foundation Malaria Grants
Mar 7, 2008
LSTM to Lead Research Program Into Malaria in...
Dec 4, 2007
Infectious Disease Research Institute Receives Grant...
More...
More on Malaria
IDRI

About the Foundation
Our Values
Our Work
Key Policies
Quick Facts
Working with Us